IGC PHARMA, INC. Finite-lived Intangible Assets Acquired
IGC PHARMA, INC. (IGC) reported Finite-lived Intangible Assets Acquired of $4.82 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-03.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2018-08-03
- IGC PHARMA, INC. finite-lived intangible assets acquired for the quarter ending 2018-06-30 was $4.82K.
| Period end | Finite-lived Intangible Assets Acquired 3 month | Finite-lived Intangible Assets Acquired 12 month |
|---|---|---|
| 2018-06-30 | $4.82K 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $127.83K 10-Q · filed 2018-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |